K
33
3
CVX
25
3
FIS
46
-2
AFL
64
2
JWN
55
2
TSCO
55
-2
CF
42
6
REGN
68
3
IFF
59
5
USB
46
9
MDT
42
-2
RL
79
3
AMZN
61
-3
FDX
53
-2
BEN
48
4
ORCL
65
9
QCOM
72
-5
YUM
52
9
AIV
60
2
FLS
55
5
K
33
3
CVX
25
3
FIS
46
-2
AFL
64
2
JWN
55
2
TSCO
55
-2
CF
42
6
REGN
68
3
IFF
59
5
USB
46
9
MDT
42
-2
RL
79
3
AMZN
61
-3
FDX
53
-2
BEN
48
4
ORCL
65
9
QCOM
72
-5
YUM
52
9
AIV
60
2
FLS
55
5
Financhill
Back

SPDR S&P® North American Natural Res ETF Vs. Cytokinetics Industry Stock Comparison

Sell
39

NANR
SPDR S&P® North American Natural Res ETF

Last Price:
54.55
Seasonality Move:
1.37%
Buy
52

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%
Sell
39
SPDR S&P® North American Natural Res ETF (NANR) is a Sell

Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?

  • The current SPDR S&P® North American Natural Res ETF [NANR] share price is $55.05. The Score for NANR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NANR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NANR Stock Price Chart

What is SPDR S&P® North American Natural Res ETF's stock price today?

  • The SPDR S&P® North American Natural Res ETF share price today is $55.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NANR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

NANR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 50.37 Buy
Chaikin Money Flow: 9336 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 57.18) Sell
Bollinger Bands (100): (50.11 - 56.93) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 69998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.06 - 56.58) Buy
Bollinger Bands (100): (56.38 - 74.98) Sell

NANR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.71 Buy
20-day SMA: 54.9 Buy
50-day SMA: 55.91 Sell
200-day SMA: 52.24 Buy
8-day EMA: 54.14 Buy
20-day EMA: 54.74 Buy
50-day EMA: 55.04 Buy
200-day EMA: 53.18 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.08 Buy
20-day SMA: 51.6 Buy
50-day SMA: 58.73 Sell
200-day SMA: 55.73 Sell
8-day EMA: 53.02 Buy
20-day EMA: 53.6 Buy
50-day EMA: 57.71 Sell
200-day EMA: 56.9 Sell

SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.08 per share.

SPDR S&P® North American Natural Res ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):